BIOMAT Database Logo BIOMAT Database Logo

New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studies. 2023

Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.

Fifteen quinazoline derivatives were designed and synthesized as DNA intercalators. The cytotoxicity of the designed members was assessed against HCT-116 and HepG2 cancer cell lines. In addition, the topoisomerase II (Topo II) inhibitory effect was assessed. Compound 16 was the most cytotoxic and Topo II inhibitor with low cytotoxicity against Vero cells. Compounds 16, 17, and 18 showed significant DNA binding affinities. Compound 16 showed Topo II catalytic inhibitory effect at a concentration of 10 μM. Further mechanistic investigations revealed the capability of compound 16 to induce apoptosis in HCT-116 cells and arrest the growth at the S and G2/M phases. Also, compound 16 showed a significant increase in the level of BAX (2.18-fold) and a marked decrease in the level of Bcl-2 (1.9-fold) compared to the control cells. In silico studies revealed the ability of the synthesized members to bind to the DNA-Topo II complex.

UI MeSH Term Description Entries
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Design and discovery of new 1,2,4-triazolo[4,3-c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors.
March 2021, Archiv der Pharmazie,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Synthesis, biological evaluation and molecular modeling study of [1,2,4]-Triazolo[4,3-c]quinazolines: New class of EGFR-TK inhibitors.
April 2020, Bioorganic & medicinal chemistry,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3-c]quinazolines as classical DNA intercalators.
April 2022, Archiv der Pharmazie,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors.
August 2016, Bioorganic & medicinal chemistry,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation.
July 2021, Bioorganic chemistry,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies.
September 2021, Bioorganic & medicinal chemistry,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors.
January 2022, Frontiers in chemistry,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
[1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
January 2021, Bioorganic & medicinal chemistry,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
November 2020, Bioorganic chemistry,
Ahmed A Gaber, and Mohamed Sobhy, and Abdallah Turky, and Wagdy M Eldehna, and Samiha A El-Sebaey, and Souad A El-Metwally, and Abeer M El-Naggar, and Ibrahim M Ibrahim, and Eslam B Elkaeed, and Ahmed M Metwaly, and Ibrahim H Eissa
Design, synthesis and biological evaluation of indole-based [1,2,4]triazolo[4,3-a] pyridine derivatives as novel microtubule polymerization inhibitors.
November 2021, European journal of medicinal chemistry,
Copied contents to your clipboard!